
Motus GI Holdings MOTS
Quarterly report 2024-Q1
added 05-14-2024
Country |
|
IPO year |
2018 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.55 M |
Market Cap[1] |
$ 263 K |
EBITDA (LTM) |
$ -11 M |
P/E (LTM) |
- |
P/S (LTM) |
0.82 |
EPS (LTM) |
-6.48 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 17.15 | 1.06 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 15.92 | 1.08 % | $ 171 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.58 | -2.78 % | $ 2.01 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 12.15 | 2.14 % | $ 345 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DexCom
DXCM
|
$ 66.09 | -1.3 % | $ 25.5 B | Nasdaq Global Select Market,SPB | ||
|
Castle Biosciences
CSTL
|
$ 38.69 | 0.16 % | $ 1.07 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.56 | 0.05 % | $ 18.8 B | Nasdaq Capital Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 227.19 | 0.3 % | $ 166 B | NYSE,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 27.03 | -0.41 % | $ 817 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.92 | -3.11 % | $ 1.07 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 102.11 | -2.99 % | $ 4.03 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Anixa Biosciences
ANIX
|
$ 3.31 | -7.68 % | $ 106 K | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 0.31 | -9.31 % | $ 9.1 M | Nasdaq Capital Market | ||
|
IQVIA Holdings
IQV
|
$ 223.83 | 0.72 % | $ 40.6 B | NYSE,SPB | ||
|
Guardant Health
GH
|
$ 103.97 | 1.86 % | $ 12.8 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 134.95 | 0.06 % | $ 21.5 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 197.68 | 2.44 % | $ 10.2 B | NYSE,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 409.44 | 1.11 % | $ 29.9 B | NYSE,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 183.97 | 0.8 % | $ 20.4 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 7.67 | -2.29 % | $ 995 M | Nasdaq Global Market | ||
|
NeoGenomics
NEO
|
$ 12.13 | 2.32 % | $ 1.54 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 6.82 | -0.66 % | $ 1.48 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 7.03 | -2.57 % | $ 637 M | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 262.25 | -0.73 % | $ 22 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 185.36 | -0.65 % | $ 15.3 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 699.6 | -0.65 % | $ 57.7 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 66.88 | 0.38 % | $ 4.63 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 140.28 | 0.44 % | $ 42.6 B | NYSE,SPB | ||
|
Biomerica
BMRA
|
$ 2.42 | -5.19 % | $ 5.56 M | Nasdaq Capital Market | ||
|
Bioventus
BVS
|
$ 7.52 | -0.46 % | $ 471 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.12 | - | $ 538 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.